CERO THERAPEUTICS HOLDINGS, INC.
CEROLoading price...
Overview
Previous Close0.0999
Open0.0871
Ask0.1100
Bid0.1021
Day's Range0.0861 - 0.1070
52 Week Range0.0500 - 206.0000
PE Ratio(TTM)--
Market Cap2.15M
Volume129.32k
Avg. Volume2.55M
12 Months Earnings-7.29M
12 Months Revenue0.00
Profit/Loss
| PARTICULARS | TTM | 2022 | 2021 |
|---|---|---|---|
| Operating Revenue | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.68M | 11.97M | 11.62M |
| Profit after Tax (Net Income) | -7.29M | -11.83M | -10.63M |
Company Profile
Sector: Healthcare
Industry: Biotechnology
HQ Location: South San Francisco, United States
Website: https://www.cero.bio
CEO & Chair: Mr. Christopher B. Ehrlich M.B.A.
Employees: 8
About Company:
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.